Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLLT10 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | NMRK1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | KIAA0430 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | TMEM241 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | RAB41 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | ZNF337 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | GOLGA8K | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | GLO1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | TAS2R19 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | TRPM6 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |